Amarin Corp Plc (AMRN)

[IgnoranceIsBliss]

Yes that's 8 to 10 year regulatory exclusivity in Europe. No one who watched the train wreck in the US is going to assume patent protection beyond that.

Like I said, the other indications would have to be CVR'ed, unless something miraculous occurs pre-buyout. Those are of course possibilities. The Kaiser trial could create interest in the long COVID thing (big maybe), BRAVE I don't know. It's a Phase II trial. Much more speculative.

Don't expect an acquirer to be as starry eyed as folks on this board about further indications. The acquirer sees a sales stream off of CVD.